Quotation Keijl, Steffen, Gilsing, Victor, Knoben, Joris, Duysters, Geert. 2016. The Two Faces of Inventions: The Relationship between Recombination and Impact in Pharmaceutical Biotechnology. Research Policy (RP) 45 (5), 1061-1074.


RIS


BibTeX

Abstract

Recombination and impact have become well established constructs to understand the origins of inventions and their importance for the development of future inventions. Despite forming these two familiar faces of inventions, their specific relationship has only marginally been subject to inquiry. To address this, this paper studies the relationship between the level of recombination of inventions and their technological impact, along two steps. First, in contrast to the common idea of a linear relationship between recombination and impact we argue that the relationship is in fact a non-linear one. Second, we distinguish between different levels of recombination (low, intermediate, high) and determine their differential impact, thereby establishing which type of recombination leads to the highest level of technological impact. We test our hypotheses on an extensive dataset, comprised of all USPTO granted patents in the biopharmaceutical industry between 1976 and 2006. Our empirical findings indicate strong evidence for a curvilinear relationship between recombination and impact. In addition, we find that an intermediate level of recombination formed by a combination of components from local, adjacent and distant knowledge domains carries the highest level of technological impact of all types of inventions. Finally, we discuss implications for the academic literature and for firms innovation strategies.

Tags

Press 'enter' for creating the tag

Publication's profile

Status of publication Published
Affiliation WU
Type of publication Journal article
Journal Research Policy (RP)
Citation Index SSCI
WU Journalrating 2009 A
WU-Journal-Rating new FIN-A, MAN-A, STRAT-A, VW-B, WH-A
Language English
Title The Two Faces of Inventions: The Relationship between Recombination and Impact in Pharmaceutical Biotechnology
Volume 45
Number 5
Year 2016
Page from 1061
Page to 1074
Reviewed? Y
URL http://www.sciencedirect.com/science/article/pii/S004873331630021X
DOI http://dx.doi.org/10.1016/j.respol.2016.02.008

Associations

People
Keijl, Steffen (Former researcher)
External
Duysters, Geert (Tilburg University, Netherlands)
Gilsing, Victor (Antwerp University, Belgium)
Knoben, Joris (Radboud University Nijmegen, Netherlands)
Organization
Strategy, Technology and Organization IN (Details)
Research areas (Ă–STAT Classification 'Statistik Austria')
5324 Organizational research (Details)
5350 Innovation research (Details)
Google Scholar: Search